Takako Murayama
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takako Murayama.
Clinical & Experimental Allergy | 1998
Akio Niimi; Ryouichi Amitani; Katsuhiro Suzuki; Eisaku Tanaka; Takako Murayama; Fumiyuki Kuze
The serum level of eosinophil cationic protein (ECP) has been used as a clinical marker in asthma, on the assumption that it reflects ongoing eosinophilic inflammation of the airways. However, only a few studies have investigated this issue, using bronchial secretions but not tissue specimens.
Thorax | 1998
Takako Murayama; Ryoichi Amitani; Yumiko Ikegami; Rieko Kawanami; Woon Joo Lee; Ryuhei Nawada
BACKGROUND Aspergillus fumigatus can colonise the airways and the lungs with localised underlying conditions and occasionally invade the surrounding lung tissues even in subjects without systemic predisposing factors, presumably by escaping the local host defences. The aim of this study was to investigate the effects of A fumigatus culture filtrate (ACF) on the activities of human phagocytes—inhibition of germination of A fumigatus spores by alveolar macrophages (AMs) and hyphal damage by polymorphonuclear leucocytes (PMNs)—which are the critical host defences against A fumigatus. METHODS Spores were incubated with AMs at a ratio of 1:1 in a medium containing different concentrations of ACF for 10 hours at 37°C. Spore germination was visualised with light microscopy and the inhibition rate was calculated. The percentage of hyphal damage caused by PMNs pretreated with various concentrations of ACF was measured by a colorimetric tetrazolium metabolic assay. RESULTS The inhibition rate of spore germination by AMs cultured with medium alone (control) was 90 (0.8)% whereas that by AMs cultured with the medium containing 10% ACF was significantly (p<0.05) reduced to 41.7 (4.6)%. ACF suppressed the inhibition of spore germination in a dose dependent manner without altering the phagocytosing activity against the spores. The percentage of hyphal damage caused by PMNs pretreated with medium-199 (control) was 78.1 (2.3)% compared with 65.3 (2.8)% when PMNs were pretreated with 50% ACF (p<0.05). CONCLUSIONS A fumigatusreleases biologically active substance(s) which suppress the inhibition of spore germination by AMs and also suppress PMN mediated hyphal damage, and thus may contribute to the pathogenicity of this fungus.
American Journal of Respiratory and Critical Care Medicine | 1997
Eisaku Tanaka; Ryoichi Amitani; Akio Niimi; Katsuhiro Suzuki; Takako Murayama; Fumiyuki Kuze
American Journal of Respiratory and Critical Care Medicine | 1999
Eisaku Tanaka; Terumi Kimoto; Kazunari Tsuyuguchi; Isao Watanabe; Hisako Matsumoto; Akio Niimi; Katsuhiro Suzuki; Takako Murayama; Ryoichi Amitani; Fumiyuki Kuze
Clinical Infectious Diseases | 1996
Ryoichi Amitani; Kazuko Nishimura; Akio Niimi; Hideki Kobayashi; Ryuhei Nawada; Takako Murayama; Hideaki Taguchi; Fumiyuki Kuze
American Journal of Respiratory and Critical Care Medicine | 2000
Eisaku Tanaka; Terumi Kimoto; Hisako Matsumoto; Kazunari Tsuyuguchi; Katsuhiro Suzuki; Sonoko Nagai; Mitsunobu Shimadzu; Hideaki Ishibatake; Takako Murayama; Ryoichi Amitani
Journal of Clinical Microbiology | 1996
R Nawada; Ryoichi Amitani; Eisaku Tanaka; Akio Niimi; Kazuo Suzuki; Takako Murayama; F Kuze
The American review of respiratory disease | 1988
Kumiko Kogishi; Mafumi Kurozumi; Yoko Fujita; Takako Murayama; Fumiyuki Kuze; Yasuhiro Suzuki
American Journal of Respiratory Cell and Molecular Biology | 1993
Katsuhiro Suzuki; Takashi Yamamoto; Atsuo Sato; Takako Murayama; Ryouichi Amitani; Kokichi Yamamoto; Fumiyuki Kuze
Clinical and Experimental Immunology | 2008
Kazuo Suzuki; Woon Joo Lee; Toru Hashimoto; Eisaku Tanaka; Takako Murayama; Ryouichi Amitani; Kokichi Yamamoto; Fumiyuki Kuze